Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page Not Available ()Premium Content



2015-01-22@07:35:02 ET
ARIAD Announces Appointment of Thomas J. DesRosier, Senior Pharmaceutical-Industry Counsel, as Chief Legal and Administrative Officer (BIZ)

2015-01-19@17:31:01 ET
Muscular Dystrophy Therapeutic Pipeline Review Research H2 2014 Report Available at RnRMarketResearch.com (PRW)

2015-01-12@11:17:42 ET
Global Orphan Drug Pipeline & Regulatory Insight 2015 (MTO)

2015-01-12@11:12:26 ET
Europe Orphan Drug Market & Clinical Trial Insight 2015 (MTO)

2014-12-18@04:24:53 ET
Malaria - Pipeline Review, H1 2014 (MTO)

2014-12-16@08:00:00 ET
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer (PRN)

2014-12-15@05:14:22 ET
Genzyme initiates treatment of first patients in multiple sclerosis study (DTM)

2014-12-03@08:38:10 ET
Fabry Disease - Pipeline Review, H2 2014 (MTO)

2014-11-21@10:36:34 ET
North America Wound Closure Devices Market Outlook to 2020 (MTO)

2014-11-10@07:00:16 ET
James M. DeTore joins bluebird bio as Chief Financial Officer (BIZ)

2014-11-07@11:05:20 ET
U-Michigan signs royalty agreement for Gaucher disease drug (UNW)

2014-10-27@07:30:22 ET
Exact Sciences Reports Third-Quarter 2014 Financial Results (BIZ)

2014-10-27@01:40:24 ET
iTraumaCare Appoints Joseph Brennan as President and CEO (CLM)

2014-10-22@09:56:28 ET
Genzyme receives FDA approval for label update of multiple sclerosis drug (DTM)

2014-10-22@06:44:29 ET
Global RNA Based Therapeutics Market 2014-2020: Market to Grow at CAGR of 28% and Reach $1.2 Billion in 2020 (MTO)